EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITORS IN TREATMENT OF NON-SMALL CELL LUNG CANCER
NOBEL MEDICUS, cilt.14, sa.3, ss.5-8, 2018 (ESCI, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 14 Sayı: 3
- Basım Tarihi: 2018
- Dergi Adı: NOBEL MEDICUS
- Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus
- Sayfa Sayıları: ss.5-8
- Hacettepe Üniversitesi Adresli: Evet
Özet
Mutation of epidermal growth factor receptor (EGFR) is one of the targeted mutations in treatment of non-small cell lung cancer (NSCLC). Mutation of EGFR occurs in 15-40% of all patients with NSCLC. In this review, efficacy of different EGFR inhibitors used in NSCLC treatment is evaluated.